Skip to main content
Premium Trial:

Request an Annual Quote

NGX Bio Raises $3M to Fund DNA Sequencing Marketplace

NEW YORK (GenomeWeb) – NGX Bio said today that it has raised $3 million, which it will use to further develop its business brokering deals between customers seeking next-generation sequencing and the facilities that provide it.

The funding round was led by 180 Degree Capital, and included Third Kind Venture Capital, Lateral Capital, the Band of Angels, and the Berkeley Angel Network, among others.

NGX was founded in 2014. It provides global online access to NGS services for both human and non-human samples, matching the sequencing needs of customers with providers who have available sequencing capacity.

In a statement, the company's President and CEO Denis Kourakin added that NGX's platform makes completion of sequencing projects simpler and more affordable, and allows customers to scale up their sequencing projects without the need for capital investment. 

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.